HEMATOLOGIC PARAMETERS AS PREDICTOR OF COVID-19 SEVERITY
Abstract
Methods: We conduct an analytical, cross-sectional, retrospective study that analyzed the hematological parameters of 97 patients with positive rRT-PCR swabs in the period of March to August 2020. Hematologic parameters of COVID 19 patients with mild and moderate-severe symptoms were compared. The receiver operating characteristic (ROC) curve, area under the curve (AUC), and Youden's index were created to determine the optimal cut-off value in predicting the degree of severity of COVID-19 patients.
Results: Statistically significant differences (p <0.05) were found in the hematological parameters of neutrophils, NLR, PLR, MLR, ALC, lymphocyte, eosinophil, SGOT, SGPT, CRP, and calcium. SGPT parameter had the highest sensitivity value (94.4%), MLR had the highest specificity value (84.5%), and Hs-CRP had the highest AUC value (AUC 0.789).
Conclusion: Certain hematological parameters may assist in early detection of the severity of a COVID-19 patient. Our findings may be useful to determine whether the patient requires hospitalization or self-isolation.
Save to Mendeley
Keywords
Full Text:
PDFReferences
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–44.
Numbers SIN. Situation Report-71 HIGHLIGHTS. 2020;2019(March).
Organization WH. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization; 2020.
Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med. 2020;8(9):593–593.
Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect. 2020;10(6):514–20.
Seddigh-shamsi M, Mahali SN, Mozdourian M, Allahyari A, Saeedian N. Investigation of hematological parameters related to the severity of COVID-19 Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad , Iran. 2021;(January).
Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020;15(8 August):1–20.
Jin J-M, Bai P, He W, Liu S, Wu F, Liu X-F, et al. Higher severity and mortality in male patients with COVID-19 independent of age and susceptibility. medRxiv. 2020;2020.02.23.20026864.
Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and Gender-Based Differences in COVID-19. Front Public Heal. 2020;8(July):1–8.
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med [Internet]. 58(7):1021–8. Available from:
https://www.degruyter.com/view/journals/cclm/58/7/article-p1021.xml
Shi L, Wang Y, Liang X, Xiao W, Duan G, Yang H, et al. Is neutrophilia associated with mortality in COVID-19 patients? A meta-analysis and meta-regression. Vol. 42, International journal of laboratory hematology. 2020. p. e244–7.
Huang J, Zhang Z, Liu S, Gong C, Chen L, Ai G, et al. Absolute Eosinophil Count Predicts Intensive Care Unit Transfer Among Elderly COVID-19 Patients From General Isolation Wards. Front Med. 2020;7:585222.
Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, et al. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis [Internet]. 2020;95:183–91. Available from: https://doi.org/10.1016/j.ijid.2020.03.013
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020 Feb;395(10223):507–13.
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Vol. 95, American journal of hematology. United States; 2020. p. E131–4.
Jiang M, Guo Y, Luo Q, Huang Z, Zhao R, Liu S, et al. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019. J Infect Dis [Internet]. 2020;222(2):198–202. Available from: https://doi.org/10.1093/infdis/jiaa252
Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T, et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacte. Yokota S, editor. Mediators Inflamm [Internet]. 2018;2018:3758068. Available from: https://doi.org/10.1155/2018/3758068
Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020;31(4):490–6.
Chan A, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12:448–53.
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–12.
Zeng F, Li L, Zeng J, Deng Y, Huang H, Chen B, et al. Can we predict the severity of coronavirus disease 2019 with a routine blood test? Polish Arch Intern Med. 2020 May;130(5):400–6.
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb;12(1):8.
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–4.
Sharma D, Dayama A, Banerjee S, Bhandhari S, Chatterjee A, Chatterjee D. To Study the Role of Absolute Lymphocyte Count and RDW in COVID 19 Patients and their Association with Appearance of Symptoms and Severity. J Assoc Physicians India. 2020 Aug;68(8):39–42.
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020;
Zahedi M, Yousefi M, Abounoori M, Malekan M, Tajik F, Heydari K, et al. Liver Function in Novel Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis. 2020;
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020;92(11):2409–11.
Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332–4.
Shang W, Dong J, Ren Y, Tian M, Li W, Hu J, et al. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020;92(10):2188–92.
Liu Y-M, Xie J, Chen M-M, Zhang X, Cheng X, Li H, et al. Kidney function indicators predict adverse outcomes of COVID-19. Med. 2020;1–11.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38.
Cappellini F, Brivio R, Casati M, Cavallero A, Contro E, Brambilla P. Low levels of total and ionized calcium in blood of COVID-19
DOI: https://doi.org/10.33508/jwm.v7i2.3335
